Although these are exciting times for digital healthcare with business processes and models enabling individuals to understand and quantify more about their health and genome than ever before, privacy remains a security concern.
“If people share their medical information with a technology company, who owns the data?” asks Caroline Rivett, head of KPMG in the UK's Information Protection team in Life Sciences and Healthcare. “How can or should the company share it? What implications does this have for the individual – and for their family members?”
This much-needed debate on privacy matters is starting in areas such as genome mapping for cancer research. But, it will need to extend beyond that to other applications, in particular medical devices.
Read our full article, including recommendations on what organisation should be doing to address these and other privacy issues.